176 related articles for article (PubMed ID: 12202289)
1. Ziprasidone alternative for olanzapine-induced hyperglycemia.
Spivak B; Alamy SS; Jarskog LF; Sheitman BB; Lieberman JA
Am J Psychiatry; 2002 Sep; 159(9):1606. PubMed ID: 12202289
[No Abstract] [Full Text] [Related]
2. Treatment of preexisting diabetes with olanzapine.
Littrell KH; Petty RG; Peabody CD; Hilligoss NM; Johnson CG
J Clin Psychiatry; 2001 Sep; 62(9):733-4. PubMed ID: 11681771
[No Abstract] [Full Text] [Related]
3. Hyperosmolar hyperglycemic state associated with ziprasidone treatment: a case report.
Létourneau G; Abdel-Baki A; Dubreucq S; Mahone M; Granger B
J Clin Psychopharmacol; 2011 Oct; 31(5):671-3. PubMed ID: 21881458
[No Abstract] [Full Text] [Related]
4. Hyperglycemia associated with olanzapine.
Fertig MK; Brooks VG; Shelton PS; English CW
J Clin Psychiatry; 1998 Dec; 59(12):687-9. PubMed ID: 9921705
[No Abstract] [Full Text] [Related]
5. Olanzapine-induced neuroleptic malignant syndrome.
Burkhard PR; Vingerhoets FJ; Alberque C; Landis T
Arch Gen Psychiatry; 1999 Jan; 56(1):101-2. PubMed ID: 9892264
[No Abstract] [Full Text] [Related]
6. Severe hypertriglyceridemia associated with olanzapine.
Stoner SC; Dubisar BM; Khan R; Farrar CD
J Clin Psychiatry; 2002 Oct; 63(10):948-9. PubMed ID: 12416606
[No Abstract] [Full Text] [Related]
7. Olanzapine-induced neutropenia.
Gajwani P; Tesar GE
Psychosomatics; 2000; 41(2):150-1. PubMed ID: 10749954
[No Abstract] [Full Text] [Related]
8. Olanzapine-induced ketoacidosis with diabetes mellitus.
Lindenmayer JP; Patel R
Am J Psychiatry; 1999 Sep; 156(9):1471. PubMed ID: 10484968
[No Abstract] [Full Text] [Related]
9. Risperidone alternative for a schizophrenic patient with olanzapine-exacerbated diabetic mellitus.
Wu PL; Lane HY; Su KP
Psychiatry Clin Neurosci; 2006 Feb; 60(1):115-6. PubMed ID: 16472369
[No Abstract] [Full Text] [Related]
10. Tardive dyskinesia associated with olanzapine monotherapy.
Ananth J; Kenan J
J Clin Psychiatry; 1999 Dec; 60(12):870. PubMed ID: 10665640
[No Abstract] [Full Text] [Related]
11. Hyperglycemia from olanzapine treatment in adolescents.
Bloch Y; Vardi O; Mendlovic S; Levkovitz Y; Gothelf D; Ratzoni G
J Child Adolesc Psychopharmacol; 2003; 13(1):97-102. PubMed ID: 12804130
[TBL] [Abstract][Full Text] [Related]
12. Recovery from new-onset diabetes in a schizophrenic man after withdrawal of olanzapine.
Melkersson K; Hulting AL
Psychosomatics; 2002; 43(1):67-70. PubMed ID: 11927762
[No Abstract] [Full Text] [Related]
13. Continuing treatment with novel antipsychotic drugs despite leukopenia or thrombocytopenia.
Jackson RS
Arch Gen Psychiatry; 2001 Jul; 58(7):706-7. PubMed ID: 11448379
[No Abstract] [Full Text] [Related]
14. Manic symptoms induced by olanzapine.
Lykouras L; Gournellis R; Angelopoulos E
Eur Neuropsychopharmacol; 2001 Apr; 11(2):97-8. PubMed ID: 11313153
[TBL] [Abstract][Full Text] [Related]
15. Aggression, agitation, and mania with olanzapine.
John V; Rapp M; Pies R
Can J Psychiatry; 1998 Dec; 43(10):1054. PubMed ID: 9868577
[No Abstract] [Full Text] [Related]
16. Propranolol treatment of olanzapine-induced akathisia.
Kurzthaler I; Hummer M; Kohl C; Miller C; Fleischhacker WW
Am J Psychiatry; 1997 Sep; 154(9):1316. PubMed ID: 9286196
[No Abstract] [Full Text] [Related]
17. Case report: possible neuroleptic malignant syndrome associated with olanzapine.
Moltz DA; Coeytaux RR
J Clin Psychopharmacol; 1998 Dec; 18(6):485-6. PubMed ID: 9864084
[No Abstract] [Full Text] [Related]
18. Acute dystonia with olanzapine.
Landry P; Cournoyer J
J Clin Psychiatry; 1998 Jul; 59(7):384. PubMed ID: 9714272
[No Abstract] [Full Text] [Related]
19. Neuroleptic malignant syndrome after the initiation of olanzapine.
Levenson JL
J Clin Psychopharmacol; 1999 Oct; 19(5):477-8. PubMed ID: 10505593
[No Abstract] [Full Text] [Related]
20. Hyperglycemia and hypertriglyceridemia secondary to olanzapine.
Domon SE; Webber JC
J Child Adolesc Psychopharmacol; 2001; 11(3):285-8. PubMed ID: 11642478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
